<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00455455</url>
  </required_header>
  <id_info>
    <org_study_id>P/245/06/L</org_study_id>
    <nct_id>NCT00455455</nct_id>
  </id_info>
  <brief_title>Corneal and Conjunctival Sensitivity and Staining Study</brief_title>
  <official_title>Corneal and Conjunctival Sensitivity and Staining Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Waterloo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Waterloo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare subjective symptoms and ocular health in a
      group of individuals who are currently wearing soft contact lenses on a daily wear basis,
      after a short period of no lens wear and during the time course when using differing care
      regimens.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to compare subjective symptoms and ocular health in a
      group of individuals who are currently wearing soft contact lenses on a daily wear basis,
      after a short period of no lens wear and during the time course when using differing care
      regimens. Observations will be made to monitor physiology.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Sensitivity</measure>
    <time_frame>baseline</time_frame>
    <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Sensitivity</measure>
    <time_frame>day 7</time_frame>
    <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Sensitivity</measure>
    <time_frame>baseline</time_frame>
    <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Sensitivity</measure>
    <time_frame>day 7</time_frame>
    <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal Staining Grade</measure>
    <time_frame>baseline</time_frame>
    <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Staining Grade</measure>
    <time_frame>day 7</time_frame>
    <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <arm_group>
    <arm_group_label>Optifree RepleniSH Multipurpose Disinfecting Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ReNu Multiplus Multipurpose Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optifree RepleniSH Multipurpose Disinfecting Solution</intervention_name>
    <description>lens care system</description>
    <arm_group_label>Optifree RepleniSH Multipurpose Disinfecting Solution</arm_group_label>
    <other_name>lens care system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ReNu Multiplus Multipurpose Solution</intervention_name>
    <description>lens care system</description>
    <arm_group_label>ReNu Multiplus Multipurpose Solution</arm_group_label>
    <other_name>lens care system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        An eligible participant is one who:

          -  Is between 17-45 years old and has full legal capacity to volunteer.

          -  Has read and signed an information consent letter, after having the opportunity to ask
             questions and receive acceptable answers.

          -  Is willing and able to follow instructions and maintain the appointment schedule.

          -  Does not experience any dryness related symptoms during lens wear (i.e. at least 12
             hours of comfortable wearing time)

          -  Is correctable to a visual acuity of 6/7.5 (20/25) or better (each eye) with their
             habitual vision correction.

          -  Has normal binocular vision (no strabismus, no amblyopia).

          -  Has clear corneas and no active ocular disease.

          -  Has had an ocular examination in the last two years. Has a distance contact lens
             prescription between +0.50D to +6.00 DS and -0.50D and -12.00 DS.

          -  Has astigmatism less than or equal to -1.00DC.

          -  Agrees to wear the study lenses on a daily wear basis.

          -  Has a pair of glasses with updated prescription and agrees to wear them during the
             period no lens wear (7-10 days) as required by the study.

        Exclusion Criteria:

        A person is ineligible if he/she:

          -  Has undergone corneal refractive surgery.

          -  Is aphakic.

          -  Has any active ocular disease.

          -  Has any systemic disease affecting ocular health.

          -  Is using any systemic or topical medications that may affect ocular health.

          -  Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study.

          -  Is pregnant or lactating.

          -  Is participating in any other clinical or research study.

          -  Has a known clinically significant sensitivity to the contact lens care solutions used
             in the study.

          -  Has ocular or systemic allergies that could adversely affect contact lens wear.

          -  Currently wears lenses on a continuous or extended wear basis.

          -  Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that
             would affect the wearing of contact lenses.

          -  Has pinguecula/pterygium that, in the investigator's judgment, makes contact lens wear
             inadvisable.

          -  Is a rigid lens wearer.

          -  Has corneal staining graded as 2 (macropunctate) or greater in any corneal region in
             either eye, sum of corneal staining type (severity) of greater than or equal to 4
             across the entire cornea in either eye, or any corneal staining covering greater than
             or equal to 20% in any corneal region in either eye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Desmond Fonn, M.Optom</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Waterloo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Contact Lens Research, School of Optometry</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2007</study_first_submitted>
  <study_first_submitted_qc>April 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2007</study_first_posted>
  <results_first_submitted>January 5, 2010</results_first_submitted>
  <results_first_submitted_qc>June 9, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 12, 2010</results_first_posted>
  <last_update_submitted>June 9, 2010</last_update_submitted>
  <last_update_submitted_qc>June 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>Craig Woods, Research Manager</name_title>
    <organization>Centre for Contact Lens Research</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants recruited from local communities in Kitchener-Waterloo, Canada between May 2007 and Feb 2008.</recruitment_details>
      <pre_assignment_details>64 participants recruited and screened; 14 withdrawn prior to the group assignment due to loss of interest, relocation and inconvenience.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RepleniSH First, Then ReNu</title>
          <description>Following a washout period, use RepleniSH for lens care in first period and ReNu in second period (after the second washout period)</description>
        </group>
        <group group_id="P2">
          <title>ReNu First, Then RepleniSH</title>
          <description>Following a washout period, use ReNu for lens care in first period and RepleniSH in second period (after the second washout period)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Washout</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Entire Study Group</title>
          <description>includes groups randomized to use RepleniSH in the 1st period and ReNu in the 2nd period, and first use ReNu and use RepleniSH in the second period.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Corneal Sensitivity</title>
        <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
        <time_frame>baseline</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in either first period or second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>Use ReNu for lens care in either first period or second period</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Sensitivity</title>
          <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>percent CO2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9" spread="13.0"/>
                    <measurement group_id="O2" value="25.5" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Staining Grade</title>
        <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
        <time_frame>baseline</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in either first period or second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>use ReNu for lens care in either first period or second period</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining Grade</title>
          <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="2.0"/>
                    <measurement group_id="O2" value="1.8" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Sensitivity</title>
        <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
        <time_frame>day 7</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in either first period or second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>use ReNu for lens care in either first period or second period</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Sensitivity</title>
          <description>The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>percent CO2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.5" spread="13.4"/>
                    <measurement group_id="O2" value="22.1" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Staining Grade</title>
        <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
        <time_frame>day 7</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in either first period or second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>use ReNu for lens care in either first period or second period</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining Grade</title>
          <description>A 0-100 grading scale based on the extent of corneal staining (0 none, 100 full area).</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="7.5"/>
                    <measurement group_id="O2" value="49.9" spread="39.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Sensitivity</title>
        <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
        <time_frame>baseline</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in either first period or second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>Use ReNu for lens care in either first period or second period</description>
          </group>
        </group_list>
        <measure>
          <title>Conjunctival Sensitivity</title>
          <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>percent CO2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.7" spread="20.2"/>
                    <measurement group_id="O2" value="49.6" spread="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Conjunctival Sensitivity</title>
        <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
        <time_frame>day 7</time_frame>
        <population>intent to treat analysis including only participants who had completed the study</population>
        <group_list>
          <group group_id="O1">
            <title>RepleniSH</title>
            <description>use RepleniSH for lens care in the first period and the second period</description>
          </group>
          <group group_id="O2">
            <title>ReNu</title>
            <description>use ReNu for lens care in the first period or the second period</description>
          </group>
        </group_list>
        <measure>
          <title>Conjunctival Sensitivity</title>
          <description>The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.</description>
          <population>intent to treat analysis including only participants who had completed the study</population>
          <units>percent CO2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.5" spread="20.2"/>
                    <measurement group_id="O2" value="46.2" spread="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>There were no adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>RepleniSH</title>
          <description>use RepleniSH for lens care in either first period or second period</description>
        </group>
        <group group_id="E2">
          <title>ReNu</title>
          <description>use ReNu for lens care in either first period or second period</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size completed as anticipated.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Craig A Woods</name_or_title>
      <organization>CCLR</organization>
      <phone>519 888 4567 ext 36547</phone>
      <email>cawoods@uwaterloo.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

